Literature DB >> 20535624

The association between antibiotic use and resistance: the role of secondary antibiotics.

J A Bosso1, P D Mauldin, C D Salgado.   

Abstract

Using susceptibility rates of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae over time as markers, we assessed the significance of the change of susceptibility rates to imipenem, ceftriaxone, cefepime, piperacillin/tazobactam, and ciprofloxacin over time and the relationship to antibiotic use for the period 2000-2006. Antibiotic use-susceptibility relationships were assessed using longitudinal regression analysis. The variables "time" and define daily doses (DDD)/1,000 patient days for the specific drug related to the susceptibility rates of that particular model's dependent variable were considered as the main effects, with significance determined at the 0.05 level. Decreases in susceptibility of the target organisms were common over the period of observation. Decreasing susceptibility trends over time were not statistically associated with the primary drug (e.g., organism susceptibility rate to imipenem with imipenem usage). However, secondary drug use was associated with susceptibility rates (e.g., susceptibility of E. cloacae to cefepime with piperacillin/tazobactam usage). These results suggest that antibiotic use-resistance relationships are influenced by the use of secondary antibiotics. Thus, a resistance problem may not be adequately addressed by simply altering the utilization of the primary antibiotic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20535624     DOI: 10.1007/s10096-010-0972-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Does increased use of antibiotics result in increased antibiotic resistance?

Authors:  P D O Davies
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

Review 2.  Ecological bias, confounding, and effect modification.

Authors:  S Greenland; H Morgenstern
Journal:  Int J Epidemiol       Date:  1989-03       Impact factor: 7.196

3.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Authors: 
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

4.  High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.

Authors:  Raul Colodner; Zmira Samra; Nathan Keller; Hanna Sprecher; Colin Block; Nehama Peled; Tzilia Lazarovitch; Rita Bardenstein; Orna Schwartz-Harari; Yehuda Carmeli
Journal:  Diagn Microbiol Infect Dis       Date:  2007-02       Impact factor: 2.803

6.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

Authors:  Marcus J Zervos; Ellie Hershberger; David P Nicolau; David J Ritchie; Lori K Blackner; Elizabeth A Coyle; Andrew J Donnelly; Stephen F Eckel; Robert H K Eng; Alexandra Hiltz; Arpi G Kuyumjian; William Krebs; Angee McDaniel; Patricia Hogan; Teresa J Lubowski
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

Review 7.  The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.

Authors:  Jeffrey R Aeschlimann
Journal:  Pharmacotherapy       Date:  2003-07       Impact factor: 4.705

8.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

Authors:  J J Rahal; C Urban; D Horn; K Freeman; S Segal-Maurer; J Maurer; N Mariano; S Marks; J M Burns; D Dominick; M Lim
Journal:  JAMA       Date:  1998-10-14       Impact factor: 56.272

9.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

10.  Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals.

Authors:  Sujata M Bhavnani; Wendy A Callen; Alan Forrest; Kristin K Gilliland; David A Collins; Joseph A Paladino; Jerome J Schentag
Journal:  Am J Health Syst Pharm       Date:  2003-10-01       Impact factor: 2.637

View more
  3 in total

1.  A cross sectional study on antibiotic resistance pattern of Salmonella typhi clinical isolates from Bangladesh.

Authors:  Adnan Mannan; Mohammad Shohel; Sultana Rajia; Niaz Uddin Mahmud; Sanjana Kabir; Imtiaj Hasan
Journal:  Asian Pac J Trop Biomed       Date:  2014-04

2.  Antibiotic consumption and its influence on the resistance in Enterobacteriaceae.

Authors:  Miroslava Htoutou Sedláková; Karel Urbánek; Vladimíra Vojtová; Hana Suchánková; Peter Imwensi; Milan Kolář
Journal:  BMC Res Notes       Date:  2014-07-16

Review 3.  The Link between Purine Metabolism and Production of Antibiotics in Streptomyces.

Authors:  Smitha Sivapragasam; Anne Grove
Journal:  Antibiotics (Basel)       Date:  2019-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.